Conceivable Life Sciences is a biotech company that uses AI and robotics to automate complex IVF procedures, including remote intracytoplasmic sperm injection (ICSI), to advance fertility care.

Rivermark Medical develops the FloStent™ System, a minimally invasive device for treating Benign Prostatic Hyperplasia (BPH) that aims to restore urinary function while preserving sexual function.